Αρχειοθήκη ιστολογίου

Πέμπτη 28 Δεκεμβρίου 2017

Letter on ‘European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis’

Abstract

We read with interest the guidelines recently published on sclerosing diseases of the skin (Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis)[1, 2]. However, we are concerned that the guideline recommendations proposed for prevention of nephrogenic systemic fibrosis (NSF) are potentially dangerous. Although we recognise the challenges in constructing comprehensive guidelines, we are concerned that this may be because the guidelines have not involved a multidisciplinary team.

This article is protected by copyright. All rights reserved.



http://ift.tt/2E91vVI

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου